Browsing tag:

BIO International Convention

United under the 2019 BIO International Convention theme, “It Starts With One,” companies, academic centers, patient groups, researchers, regulatory leaders and investors worked to progress approaches in key areas, such as drug development, patient access, gene therapy, diversity and inclusion, opioids, renewable fuels and agriculture. BIO 2019 featured over 1,800 exhibitors, more than 800 speakers,[…]

Read More

NASHVILLE, Tennessee – LGM Pharma was represented at the International Bio Conference in Boston June 18 – 21 by our sales team, who met with several clients and prospective clients. The Company successfully expanded its network of custom manufacturing partners, most notably in biologics, which was a dominant theme at the BIO International Convention. The[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service